Revisiting Race and the Benefit of RAS Blockade in Heart Failure
Article 2024 en
Authors
LS
Li Shen
ML
Matthew M.Y. Lee
PJ
Pardeep S. Jhund
Abstract
1 min read
The mortality benefit from RAS blockade was similar in Black and non-Black patients. Despite the smaller relative risk reduction in hospitalization for HF with RAS blockade in Black patients, the absolute benefit in Black patients was comparable with non-Black patients because of the greater incidence of this outcome in Black patients.
Toru Kondo, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo Maggioni, Felipe A Martinez, M REDFIELD, Jean‐Lucien Rouleau, D.J. van Veldhuisen, Faı̈ez Zannad, Michael R. Zile, Milton Packer, Scott D. Solomon, John J.V. McMurray
Stephen J. Greene, Mihai Gheorghiade, Muthiah Vaduganathan, Andrew P. Ambrosy, Robert J. Mentz, Haris Subačius, Aldo Maggioni, Savina Nodari, Marvin A. Konstam, Javed Butler, Gerasimos Filippatos
Discussion(0)
No comments yet. Be the first to comment.